Correction
Accepted on 20 Feb 2024
Corrigendum: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
in Pharmacology of Anti-Cancer Drugs
- 159 views
Correction
Accepted on 20 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Case Report
Published on 15 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 15 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Review
Published on 12 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Brief Research Report
Published on 02 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 29 Jan 2024
in Pharmacology of Anti-Cancer Drugs
Review
Published on 29 Jan 2024
in Pharmacology of Anti-Cancer Drugs
Review
Published on 18 Jan 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 11 Jan 2024
in Pharmacology of Anti-Cancer Drugs
Editorial
Published on 04 Jan 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 03 Jan 2024
in Pharmacology of Anti-Cancer Drugs
Review
Published on 19 Dec 2023
in Pharmacology of Anti-Cancer Drugs
Review
Published on 13 Dec 2023
in Pharmacology of Anti-Cancer Drugs
Review
Published on 12 Dec 2023
in Pharmacology of Anti-Cancer Drugs
Retraction
Published on 07 Dec 2023
in Pharmacology of Anti-Cancer Drugs
Systematic Review
Published on 06 Dec 2023
in Pharmacology of Anti-Cancer Drugs